| Identifier | Protein names | Gene names | Cross reference refseq | Length | Species |
| Q7Y7U2 | NADH-ubiquinone oxidoreductase chain 1; EC 1.6.5.3; | ND1; | NULL | 318 | human |
| B7Z6R6 | Tetratricopeptide repeat protein 26; cDNA FLJ55883; | TTC26; | NULL | 447 | human |
| I3Q2Q4 | NADH-ubiquinone oxidoreductase chain 6; EC 1.6.5.3; | ND6; | NULL | 174 | human |
| D8L5G9 | NADH-ubiquinone oxidoreductase chain 6; EC 1.6.5.3; | ND6; | NULL | 174 | human |
| Q2LC95 | MHC class I antigen; | HLA-A; | NULL | 365 | human |
| U5XJY8 | LILRB3; Fragment; | LILRB3; | NULL | 589 | human |
| K4DIA0 | ICOS ligand; Inducible T-cell co-stimulator ligand, isoform CRA_b; | ICOSLG; | XP_005261155.1; | 473 | human |
| E5RFX9 | MAPK/MAK/MRK overlapping kinase; | MOK; | NULL | 44 | human |
| Q06TE6 | Cytochrome c oxidase subunit 2; | COX2; | NULL | 227 | human |
| A7MAP4 | HLA class I histocompatibility antigen, A-68 alpha chain; MHC class I antigen; | HLA-A; | NULL | 356 | human |
| B9A012 | Myosin VIIA, isoform CRA_a; Unconventional myosin-VIIa; | MYO7A; | NP_001120651.2; | 1178 | human |
| E1B2Z5 | Cytochrome b; | CYTB; | NULL | 380 | human |
| Q2MJJ5 | MHC class I antigen; Major histocompatibility complex, class I, A; | HLA-A; | NULL | 365 | human |
| Q5Y7D7 | MHC class II antigen; Major histocompatibility complex, class II, DR beta 1; | HLA-DRB1; | NULL | 266 | human |
| Q2HJV5 | NADH-ubiquinone oxidoreductase chain 1; EC 1.6.5.3; | ND1; NADH1; | NULL | 318 | human |
| B2RG49 | Zinc finger and BTB domain containing 7C; | ZBTB7C; | NP_001034449.1;XP_005258284.1;XP_005258286.1;XP_005258287.1;XP_006722480.1;XP_006722481.1; | 619 | human |
| C6K6J1 | MHC class I antigen; | HLA-B; | NULL | 362 | human |
| Q5Q757 | NADH-ubiquinone oxidoreductase chain 1; EC 1.6.5.3; Fragment; | ND1; | NULL | 130 | human |
| C9J4G5 | EGF domain-specific O-linked N-acetylglucosamine transferase; HCG1777404, isoform CRA_a; HCG1777404, isoform CRA_b; Fragment; | EOGT; | NULL | 124 | human |
| A1BQX2 | MARVEL domain-containing protein 2; Tricellulin isoform c; | MARVELD2; | NULL | 442 | human |
UrgentMab™: Thinking is cheap. Test your ideas, fast and furious. |
 |
|
Custom monoclonal antibody in one month. As low as $200-300 per antigen. |
|
A product of Absolution |
|
SEAL™: Today's out-of-reach protein targets made accessible. |
|
|
Same budget, 5-10 times more antibodying SEAL your protein. Successes too. |
|
A product of Absolution |
|
PETAL™: Fast and high throughput antibody discover platform. |
 |
|
Deliver customized antibody in two weeks at price of category antibody Proteome-scale antibody discovery for any organism or proteome Biomarker discovery for biological processes or human diseases |
|
A product of Absolution |
|
AbFocus™: Target all the modification sites of your protein, affordably. |
|
|
Test them with a panel of AbFocus antibodies It is so affordable that you can focus on testing, not guessing |
|
A product of Absolution |
Mabome™: Catch the antibody gold rush.? Lead the next omics revolution. |
|
|
First-ever antibody proteomics technology. High quality monoclonal antibodies for your favorite proteome. As low as $19/monoclonal antibody |
|
A product of Absolution |
AbTarget™: Performing antibody for your proteome.? Guaranteed |
|
|
Fast, efficient monoclonal antibody development for proteins in a proteome Pay for successful antibodies only |
|
A product of Absolution |
AbProfile™: Discover an array of unbiased differences.? Proteome-scale |
|
|
50,000 monoclonal antibodies on an array.100 times more content. Differential profiling thousands of cell surface receptorsand plasma proteins |
|
A product of Absolution |
|
SMAL™:?All big things have a SMAL beginning. |
|
|
High success rate for mAb generation Deliver a panel of high affinity mAbs Flexible and optional fee structure for minimizing risks |
|
A product of Absolution |
AbX™: X=anything.? Find your antibody within |
|
|
currently 7species.?200,000 mAbs.70,000 proteins 3 new organisms are being AbXed/day Pre-made anti-peptide mAbs against all proteins in nature. |
|
A product of AbStore |
AbStop™: The last stop of antibody development. The most successful stop. |
|
|
Pre-designed antibody packages against high value targets The most aggressive and comprehensive protein targeting Best for diagnostics and therapeutic antibody development |
|
A product of AbStore |